Cytek Biosciences CTKB Balance Sheet (2020-2026)

NASDAQ CTKB
$5.82 +0.06 (+1.04%)
As of: Sep 30, 2026 · 1:02 PM EDT
Reported Financials

Cytek Biosciences Quarterly Balance Sheet

Periods 25 quarters
Latest Jun 2026

Cytek Biosciences reported total assets of $446.93M and total liabilities of $124.98M for the quarter ended Jun 2026, down 9.4% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
376.80M364.62M362.51M349.90M341.52M296.60M129.50M131.54M163.63M167.30M168.79M177.89M162.27M98.72M95.30M75.47M93.28M90.90M65.70M73.85M
Cash & Current Investments
376.80M364.62M362.51M349.90M341.52M296.60M129.50M131.54M163.63M167.30M168.79M177.89M162.27M98.72M95.30M75.47M93.28M90.90M65.70M73.85M
Receivables - NetNet Receivables
29.45M29.76M30.41M36.81M39.64M48.86M43.10M49.62M55.40M55.93M50.31M44.64M52.63M60.59M55.03M56.23M56.63M62.51M51.90M49.70M
Receivables - OtherOther Receivables
1.59M
Receivables
29.45M29.76M31.99M36.81M39.64M48.86M43.10M49.62M55.40M55.93M50.31M44.64M52.63M60.59M55.03M56.23M56.63M62.51M51.90M49.70M
Raw Materials
15.37M17.26M21.18M25.83M28.50M26.93M42.18M39.82M37.27M35.72M33.52M29.83M26.80M22.57M23.74M24.87M24.65M20.44M23.64M22.91M
Work In Process
1.99M2.30M1.51M2.48M5.41M4.90M4.54M5.61M11.93M10.45M6.27M6.03M6.14M6.49M6.39M7.67M6.73M16.53M16.34M15.84M
Finished Goods
10.15M12.61M15.30M17.04M15.46M16.33M22.78M20.31M17.68M14.71M14.95M14.21M13.86M14.83M15.22M16.94M20.26M11.46M9.81M13.50M
Inventory
27.51M32.17M37.98M45.34M49.37M48.15M69.50M65.73M66.88M60.88M54.74M50.07M46.80M43.89M45.35M49.49M51.65M48.43M49.79M52.25M
Prepaid Assets
6.09M5.18M8.22M11.22M13.33M12.95M11.11M10.63M12.02M12.51M13.16M12.13M12.95M14.07M14.51M15.08M18.47M19.53M15.38M13.98M
Current Assets
439.83M431.73M439.11M443.27M443.86M454.02M425.62M424.82M422.31M392.06M388.65M384.08M390.19M396.45M380.50M382.82M388.49M392.00M379.30M377.93M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
4.98M5.85M6.50M7.34M7.84M13.68M15.55M15.59M17.41M18.41M18.25M18.11M18.51M17.96M17.83M18.35M18.05M18.01M20.47M20.80M
Goodwill
0.48M10.14M10.14M10.14M10.14M10.14M19.14M19.14M16.46M16.18M16.18M16.18M16.18M16.66M16.68M16.71M16.70M16.70M16.69M16.69M
Intangibles
0.36M4.74M4.33M3.86M4.49M4.33M24.66M23.68M24.29M23.08M22.25M21.42M20.49M20.13M19.43M18.60M17.68M16.82M15.70M14.87M
Goodwill & Intangibles
0.84M14.88M14.47M14.00M14.63M14.47M43.81M42.83M40.75M39.27M38.44M37.60M36.67M36.79M36.11M35.31M34.37M33.52M32.39M31.55M
Other Non-Current Assets
1.30M1.67M1.26M2.88M4.56M2.96M3.01M3.01M3.17M3.38M4.08M4.92M4.95M4.76M4.57M4.68M4.46M6.70M6.31M5.68M
Non-Current Assets
14.49M31.57M46.77M49.55M55.44M65.46M98.95M100.23M97.11M102.40M103.42M99.64M101.03M103.05M102.09M110.50M106.43M69.55M69.81M69.00M
Assets
454.32M463.31M485.88M492.82M499.30M519.48M524.58M525.05M519.43M494.46M492.07M483.73M491.23M499.50M482.60M493.32M494.92M461.54M449.11M446.93M
Liabilities
Current Liabilities
Accounts Payables
3.93M3.03M5.97M6.75M5.64M4.80M5.28M3.08M4.71M3.03M3.73M3.19M5.39M5.53M6.25M6.85M7.63M6.41M6.74M8.41M
Payables
3.93M3.03M5.97M6.75M5.64M4.80M5.28M3.08M4.71M3.03M3.73M3.19M5.39M5.53M6.25M6.85M7.63M6.41M6.74M8.41M
Accumulated Expenses
10.75M15.25M14.64M17.84M16.64M21.13M20.37M19.59M20.51M20.04M18.05M15.49M20.73M21.44M19.20M21.60M20.23M23.42M19.78M23.86M
Other Accumulated Expenses
2.04M6.35M8.39M5.63M4.95M7.96M10.86M8.39M7.82M7.90M8.23M7.23M8.81M13.49M12.84M14.72M16.43M16.98M22.17M20.51M
Current Taxes
0.49M2.48M2.74M0.25M0.25M0.25M
Current Deferred Revenue
5.88M7.08M12.25M9.99M12.09M12.99M18.10M20.61M23.05M22.70M23.01M23.97M25.36M25.49M27.71M28.13M28.74M28.50M30.03M29.21M
Total Current Liabilities
30.01M33.18M42.80M42.35M41.49M49.04M56.52M53.59M58.69M56.23M55.57M52.38M62.80M67.66M67.69M73.27M75.21M77.80M80.94M84.33M
Non-Current Liabilities
Non-Current Deffered Revenue
7.74M9.79M7.20M11.02M10.41M13.12M13.01M16.05M14.96M15.13M15.16M14.06M14.79M16.10M15.72M16.62M16.32M18.34M17.67M18.06M
Preferred Stock Liabilities
Operating Leases
12.31M12.32M14.33M12.31M11.54M10.83M10.14M9.48M8.70M8.11M7.76M7.55M7.45M14.12M13.49M14.04M13.44M13.52M
Other Non-Current Liabilities
12.63M13.74M14.63M14.65M15.12M15.60M16.05M16.46M16.09M16.48M16.72M16.91M17.07M9.04M8.82M8.48M8.16M6.79M6.64M6.37M
Total Non-Current Liabilities
38.49M44.17M63.80M67.04M67.66M78.33M85.07M84.41M87.81M84.92M82.73M77.69M88.70M94.73M94.15M107.29M108.19M113.02M114.83M118.61M
Total Liabilities
51.12M57.92M78.44M81.69M82.79M93.93M101.11M100.88M103.91M101.39M99.45M94.60M105.76M103.76M102.97M115.76M116.35M119.80M121.47M124.98M
Shareholder's Equity
Common Equity
403.19M405.38M407.44M411.13M416.51M425.55M423.46M424.18M415.52M393.06M392.61M389.12M385.46M395.74M379.62M377.56M378.57M341.74M327.64M321.95M
Liabilities and Shareholders Equity
454.32M463.31M485.88M492.82M499.30M519.48M524.58M525.05M519.43M494.46M492.07M483.73M491.23M499.50M482.60M493.32M494.92M461.54M449.11M446.93M
Retained Earnings
-18.41M-19.61M-21.63M-22.23M-20.56M-17.03M-23.84M-28.23M-34.68M-29.18M-35.35M-45.78M-44.84M-35.20M-46.60M-52.18M-57.66M-101.74M-120.60M-132.76M

Cytek Biosciences Balance Sheet API

Pull Cytek Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CTKB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY